International Journal of Celiac Disease
ISSN (Print): 2334-3427 ISSN (Online): 2334-3486 Website: Editor-in-chief: Samasca Gabriel
Open Access
Journal Browser
International Journal of Celiac Disease. 2020, 8(2), 68-75
DOI: 10.12691/ijcd-8-2-8
Open AccessArticle

COVID-19 Pandemic an Update for Celiac Community

Madalina Bordea1, Gina Klein2, Liliana Salanta2, Diana Muntean2, Florentina Urda2, Adriana Dolha2, Camelia Samsudean2, Viorica Trifan2, Anca Ples2, Vera Pop2, Lelia Hosu2, Aletta Danyi2, Roxana Piscoran2, Rares Rus2, Patricia Rus2, Cristian Lutai2, Ana Copaciu2, Corina Tritean2, Carmen Nylas2, Ciprian Silaghi3, Sorin Man2, 4, Cornel Aldea2, 5 and Gabriel Samasca2, 6,

1Department of Microbiology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania

2Emergency Hospital for Children, Cluj-Napoca, Romania

3Department of Biochemistry, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania

4Department of Pediatrics III, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania

5Department of Pediatrics II, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania

6Department of Immunology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania

Pub. Date: June 25, 2020

Cite this paper:
Madalina Bordea, Gina Klein, Liliana Salanta, Diana Muntean, Florentina Urda, Adriana Dolha, Camelia Samsudean, Viorica Trifan, Anca Ples, Vera Pop, Lelia Hosu, Aletta Danyi, Roxana Piscoran, Rares Rus, Patricia Rus, Cristian Lutai, Ana Copaciu, Corina Tritean, Carmen Nylas, Ciprian Silaghi, Sorin Man, Cornel Aldea and Gabriel Samasca. COVID-19 Pandemic an Update for Celiac Community. International Journal of Celiac Disease. 2020; 8(2):68-75. doi: 10.12691/ijcd-8-2-8


Nobody believed in a new pandemic this year. COVID19 pandemic is a public health issue. The evolution of the COVID19 pandemic is important to be known by everyone in the medical world. Our goals in this narrative review were to analyze novel coronavirus from all points of view: epidemiology, clinical, and the relationship with Influenza Virus.

epidemiology novel virus asymptomatic carriers clinical manifestations imaging characteristics laboratory tests

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


[1]  Giwa A, Desai A. Novel coronavirus COVID-19: an overview for emergency clinicians. Emerg Med Pract. 2020; 22: 1-21.
[2]  Furuya T, Macnaughton TB, La Monica N, Lai MM. Natural evolution of coronavirus defective-interfering RNA involves RNA recombination. Virology. 1993; 194: 408-413.
[3]  Sohrabi C, Alsafi Z, O'Neill N, et al. World Health Organization declares Global Emergency: A review of the 2019 Novel Coronavirus (COVID-19]. Int J Surg. 2020; 76: 71-76.
[4]  Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382: 727-733.
[5]  [No authors listed]. Voice from China: nomenclature of the novel coronavirus and related diseases. Chin Med J (Engl). 2020; 133: 1012-1014.
[6]  Phan T. Genetic diversity and evolution of SARS-CoV-2. Infect Genet Evol. 2020; 81: 104260.
[7]  Park WB, Kwon NJ, Choi SJ, et al. Virus Isolation from the First Patient with SARS-CoV-2 in Korea. J Korean Med Sci. 2020; 35: e84.
[8]  Cleemput S, Dumon W, Fonseca V, et al. Genome Detective Coronavirus Typing Tool for rapid identification and characterization of novel coronavirus genomes. Bioinformatics. 2020; 36: 3552-3555.
[9]  Samasca G, Man S, Cristea V, Puscas V. XXI’s century epidemics – political aspects and diagnosis. Rom J Infect Dis 2012; 15: 39-43.
[10]  Sun P, Lu X, Xu C, et al. Understanding of COVID-19 based on current evidence. J Med Virol. 2020;
[11]  Du Z, Wang L, Cauchemez S, et al. Risk for Transportation of 2019 Novel Coronavirus Disease from Wuhan to Other Cities in China. Emerg Infect Dis. 2020; 26: 1049-1052.
[12]  Zhang J, Ma K, Li H, et al. The continuous evolution and dissemination of 2019 novel human coronavirus. J Infect. 2020; 80: 671-693.
[13]  Li Q, Guan X, Wu P, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020; 382: 1199-1207.
[14]  Ralph R, Lew J, Zeng T, et al. 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness. J Infect Dev Ctries. 2020; 14: 3-17.
[15]  Zhao WM, Song SH, Chen ML, et al. The 2019 novel coronavirus resource. Yi Chuan. 2020; 42: 212-221.
[16]  Han Q, Lin Q, Jin S, You L. Coronavirus 2019-nCoV: A brief perspective from the front line. J Infect. 2020; 80: 373-377.
[17]  Jalava K. First respiratory transmitted food borne outbreak? Int J Hyg Environ Health. 2020; 226: 113490.
[18]  Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020; 41: 145-151.
[19]  Yi H. 2019 novel coronavirus is undergoing active recombination. Clin Infect Dis. 2020.
[20]  Cheng ZJ, Shan J. 2019 Novel coronavirus: where we are and what we know. Infection. 2020; 48: 155-163.
[21]  Hu JX, He GH, Liu T, et al. [Risk assessment of exported risk of novel coronavirus pneumonia from Hubei Province]. Zhonghua Yu Fang Yi Xue Za Zhi. 2020; 54: E017.
[22]  Cascella M, Rajnik M, Cuomo A, et al. Features, Evaluation and Treatment Coronavirus (COVID-19). StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-2020 Mar 8.
[23]  Roosa K, Lee Y, Luo R, et al. Real-time forecasts of the COVID-19 epidemic in China from February 5th to February 24th, 2020. Infect Dis Model. 2020; 5: 256-263.
[24]  Deng SQ, Peng HJ. Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China. J Clin Med. 2020; 9: 575.
[25]  She J, Jiang J, Ye L, et al. 2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies. Clin Transl Med. 2020; 9: 19.
[26]  Kobayashi T, Jung SM, Linton NM, et al. Communicating the Risk of Death from Novel Coronavirus Disease (COVID-19). J Clin Med. 2020; 9: 580.
[27]  Liu Z, Xiao X, Wei X, et al. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2. J Med Virol. 2020.
[28]  Nishiura H, Linton NM, Akhmetzhanov AR. Initial Cluster of Novel Coronavirus (2019-nCoV) Infections in Wuhan, China Is Consistent with Substantial Human-to-Human Transmission. J Clin Med. 2020; 9: 488.
[29]  Fan HH, Wang LQ, Liu WL, et al. Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus (2019-nCoV) related coronavirus model. Chin Med J (Engl). 2020; 133: 1051-1056.
[30]  Salata C, Calistri A, Parolin C, Palù G. Coronaviruses: a paradigm of new emerging zoonotic diseases. Pathog Dis. 2019; 77.
[31]  Wassenaar TM, Zou Y. 2019_nCoV: Rapid classification of betacoronaviruses and identification of traditional Chinese medicine as potential origin of zoonotic coronaviruses. Lett Appl Microbiol. 2020; 70: 342-348.
[32]  Respiratory care committee of Chinese Thoracic Society. [Expert consensus on preventing nosocomial transmission during respiratory care for critically ill patients infected by 2019 novel coronavirus pneumonia]. Zhonghua Jie He He Hu Xi Za Zhi. 2020; 17: E020.
[33]  Zuo MZ, Huang YG, Ma WH, et al. Expert Recommendations for Tracheal Intubation in Critically ill Patients with Noval Coronavirus Disease 2019. Chin Med Sci J. 2020.
[34]  Tong ZD, Tang A, Li KF, et al. Potential Presymptomatic Transmission of SARS-CoV-2, Zhejiang Province, China, 2020. Emerg Infect Dis. 2020; 26: 1052-1054.
[35]  Luo SH, Liu W, Liu ZJ, et al. A confirmed asymptomatic carrier of 2019 novel coronavirus (SARS-CoV-2). Chin Med J (Engl). 2020; 133: 1123-1125.
[36]  Yu P, Zhu J, Zhang Z, et al. A familial cluster of infection associated with the 2019 novel coronavirus indicating potential person-to-person transmission during the incubation period. J Infect Dis. 2020.
[37]  Bae JM. A Chinese Case of COVID-19 Did Not Show Infectivity During the Incubation Period: Based on an Epidemiological Survey. J Prev Med Public Health. 2020.
[38]  Special Expert Group for Control of the Epidemic of Novel Coronavirus Pneumonia of the Chinese Preventive Medicine Association. [An update on the epidemiological characteristics of novel coronavirus pneumonia(COVID-19]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020; 41: 139-144.
[39]  Lauer SA, Grantz KH, Bi Q, et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann Intern Med. 2020; 172: 577-582.
[40]  Zhang W, Du RH, Li B, et al. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect. 2020; 9: 386-389.
[41]  Thompson RN. Novel Coronavirus Outbreak in Wuhan, China, 2020: Intense Surveillance Is Vital for Preventing Sustained Transmission in New Locations. J Clin Med. 2020; 9: 498.
[42]  Han Q, Lin Q, Ni Z, You L. Uncertainties about the transmission routes of 2019 novel coronavirus. Influenza Other Respir Viruses. 2020.
[43]  Boldog P, Tekeli T, Vizi Z, et al. Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China. J Clin Med. 2020; 9: 571.
[44]  Cai JH, Wang XS, Ge YL, et al. [First case of 2019 novel coronavirus infection in children in Shanghai]. Zhonghua Er Ke Za Zhi. 2020; 58: 86-87.
[45]  Wang D, Ju XL, Xie F, et al. [Clinical analysis of 31 cases of 2019 novel coronavirus infection in children from six provinces (autonomous region) of northern China]. Zhonghua Er Ke Za Zhi. 2020; 58: E011.
[46]  Cheng JL, Huang C, Zhang GJ, et al. [Epidemiological characteristics of novel coronavirus pneumonia in Henan]. Zhonghua Jie He He Hu Xi Za Zhi. 2020; 43: E027.
[47]  Bernard Stoecklin S, Rolland P, Silue Y, et al. First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020. Euro Surveill. 2020; 25: 2000094.
[48]  Albarello F, Pianura E, Di Stefano F, et al. 2019-novel Coronavirus severe adult respiratory distress syndrome in two cases in Italy: An uncommon radiological presentation. Int J Infect Dis. 2020; 93: 192-197.
[49]  Lillie PJ, Samson A, Li A, et al. Novel coronavirus disease (Covid-19): the first two patients in the UK with person to person transmission. J Infect. 2020; 80: 578-606.
[50]  Haider N, Yavlinsky A, Simons D, et al. Passengers' destinations from China: low risk of Novel Coronavirus (2019-nCoV) transmission into Africa and South America. Epidemiol Infect. 2020; 148: e41.
[51]  Jernigan DB, CDC COVID-19 Response Team. Update: Public Health Response to the Coronavirus Disease 2019 Outbreak - United States, February 24, 2020. MMWR Morb Mortal Wkly Rep; 69: 216-219.
[52]  Silverstein WK, Stroud L, Cleghorn GE, Leis JA. First imported case of 2019 novel coronavirus in Canada, presenting as mild pneumonia. Lancet. 2020; 395: 734.
[53]  Sookaromdee P, Wiwaniveitkit V. Imported Novel Coronavirus Infections: Observation on Active and Passive Case Detection in Thailand. Popul Health Manag. 2020.
[54]  Bastola A, Sah R, Rodriguez-Morales AJ, et al. The first 2019 novel coronavirus case in Nepal. Lancet Infect Dis. 2020; 20: 279-280.
[55]  Zhang S, Diao M, Yu W, et al. Estimation of the reproductive number of Novel Coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis. Int J Infect Dis. 2020; 93: 201-204.
[56]  Anzai A, Kobayashi T, Linton NM, et al. Assessing the Impact of Reduced Travel on Exportation Dynamics of Novel Coronavirus Infection (COVID-19). J Clin Med. 2020; 9: 601.
[57]  Quilty BJ, Clifford S, Flasche S, et al. Effectiveness of airport screening at detecting travellers infected with novel coronavirus (2019-nCoV). Euro Surveill. 2020; 25: 2000080.
[58]  Xiao C. A Novel Approach of Consultation on 2019 Novel Coronavirus (COVID-19)-Related Psychological and Mental Problems: Structured Letter Therapy. Psychiatry Investig. 2020; 17: 175-176.
[59]  Zhou X. Psychological crisis interventions in Sichuan Province during the 2019 novel coronavirus outbreak. Psychiatry Res. 2020; 286: 112895.
[60]  Cinteza M. COVID 19. A Flash in Mid-March. MAEDICA – a Journal of Clinical Medicine. 2020; 15: 3-5.
[61]  Cheng JQ. [Thoughts and suggestions on modern construction of disease prevention and control system]. Zhonghua Yu Fang Yi Xue Za Zhi. 2020; 54: 1-5.
[62]  Special Expert Group for Control of the Epidemic of Novel Coronavirus Pneumonia of the Chinese Preventive Medicine Association. [Recommendation on the modernization of disease control and prevention]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020; 41: 453-460.
[63]  Azamfirei R. The 2019 Novel Coronavirus: A Crown Jewel of Pandemics? J Crit Care Med (Targu Mures). 2020; 6: 3-4.
[64]  Tang B, Bragazzi NL, Li Q, et al. An updated estimation of the risk of transmission of the novel coronavirus (2019-nCov). Infect Dis Model. 2020; 5: 248-255.
[65]  Linton NM, Kobayashi T, Yang Y, et al. Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data. J Clin Med. 2020; 9: 538.
[66]  Jiang X, Rayner S, Luo MH. Does SARS-CoV-2 has a longer incubation period than SARS and MERS? J Med Virol. 2020; 92: 476-478.
[67]  Zhao L, Zhang L, Liu JW, et al. [The treatment proposal for the patients with breast diseases in the central epidemic area of 2019 coronavirus disease]. Zhonghua Wai Ke Za Zhi. 2020; 58: E005.
[68]  Xu X, Yu C, Qu J, et al. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2. Eur J Nucl Med Mol Imaging. 2020; 47: 1275-1280.
[69]  Xia J, Tong J, Liu M, et al. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol. 2020.
[70]  Li JO, Lam DSC, Chen Y, Ting DSW. Novel Coronavirus disease 2019 (COVID-19): The importance of recognising possible early ocular manifestation and using protective eyewear. Br J Ophthalmol. 2020; 104: 297-298.
[71]  Society of public health ophthalmology, Chinese preventive medicine association; Beijing ophthalmological society and youth committee of Beijing ophthalmological society. [Suggestions from ophthalmic experts on eye protection during the novel coronavirus pneumonia epidemic]. Zhonghua Yan Ke Za Zhi. 2020; 56: E002.
[72]  Lai CC, Shih TP, Ko WC, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020; 55: 105924.
[73]  Sun P, Qie S, Liu Z, et al. Clinical Characteristics of Hospitalized Patients With SARS-CoV-2 Infection: A Single Arm Meta-Analysis. J Med Virol. 2020.
[74]  74. Tian XL, Peng M, Wang HP, et al. [The differential diagnosis for novel coronavirus pneumonia and similar lung diseases in general hospitals]. Zhonghua Jie He He Hu Xi Za Zhi. 2020; 43: E035.
[75]  Xu XW, Wu XX, Jiang XG, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020; 368: m606.
[76]  Cai J, Xu J, Lin D, et al. A Case Series of children with 2019 novel coronavirus infection: clinical and epidemiological features. Clin Infect Dis. 2020.
[77]  Yoon SH, Lee KH, Kim JY, et al. Chest Radiographic and CT Findings of the 2019 Novel Coronavirus Disease (COVID-19): Analysis of Nine Patients Treated in Korea. Korean J Radiol. 2020; 21: 494-500.
[78]  Pan Y, Guan H, Zhou S, et al. Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China. Eur Radiol. 2020; 30: 3306-3309.
[79]  Ai T, Yang Z, Hou H, et al. Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology. 2020.
[80]  Wei J, Xu H, Xiong J, et al. 2019 Novel Coronavirus (COVID-19) Pneumonia: Serial Computed Tomography Findings. Korean J Radiol. 2020; 21: 501-504.
[81]  Zu ZY, Jiang MD, Xu PP, et al. Coronavirus Disease 2019 (COVID-19): A Perspective from China. Radiology. 2020.
[82]  Kim H. Outbreak of novel coronavirus (COVID-19): What is the role of radiologists? Eur Radiol. 2020; 30: 3266-3267.
[83]  Pan F, Ye T, Sun P, et al. Time Course of Lung Changes On Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia. Radiology. 2020; 295: 715-721.
[84]  Feng K, Yun YX, Wang XF, et al. [Analysis of CT features of 15 Children with 2019 novel coronavirus infection]. Zhonghua Er Ke Za Zhi. 2020; 58: E007.
[85]  Lin C, Ding Y, Xie B, et al. Asymptomatic novel coronavirus pneumonia patient outside Wuhan: The value of CT images in the course of the disease. Clin Imaging. 2020; 63: 7-9.
[86]  Ma FH, Hu HT, Tian YT. [Surgical treatment strategy for digestive system malignancies during the outbreak of novel coronavirus pneumonia]. Zhonghua Zhong Liu Za Zhi. 2020; 42: E001.
[87]  Liu W, Tao ZW, Lei W, et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J (Engl). 2020; 133: 1032-1038.
[88]  Liu M, He P, Liu HG, et al. [Clinical characteristics of 30 medical workers infected with new coronavirus pneumonia]. Zhonghua Jie He He Hu Xi Za Zhi. 2020; 43: E016.
[89]  Tang N, Li D, Wang X, Sun Z. Abnormal Coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18: 844-847.
[90]  Li Z, Yi Y, Luo X, et al. Development and Clinical Application of A Rapid IgM-IgG Combined Antibody Test for SARS-CoV-2 Infection Diagnosis. J Med Virol. 2020.
[91]  Hao W. Clinical Features of Atypical 2019 Novel Coronavirus Pneumonia with an initially Negative RT-PCR Assay. J Infect. 2020; 80: 671-693.
[92]  Ruan ZR, Gong P, Han W, et al. A case of 2019 novel coronavirus infected pneumonia with twice negative 2019-nCoV nucleic acid testing within 8 days. Chin Med J (Engl). 2020.
[93]  Chen W, Lan Y, Yuan X, et al. Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity. Emerg Microbes Infect. 2020; 9: 469-473.
[94]  Li YY, Wang WN, Lei Y, et al. [Comparison of the clinical characteristics between RNA positive and negative patients clinically diagnosed with 2019 novel coronavirus pneumonia]. Zhonghua Jie He He Hu Xi Za Zhi. 2020; 43: E023.
[95]  Zhang R, Li JM. [The way to reduce the"false negative results"of 2019 novel coronavirus nucleic acid detection]. Zhonghua Yi Xue Za Zhi. 2020; 100: E008.
[96]  Bai SL, Wang JY, Zhou YQ, et al. [Analysis of the first cluster of cases in a family of novel coronavirus pneumonia in Gansu Province]. Zhonghua Yu Fang Yi Xue Za Zhi. 2020; 54: E005.
[97]  Ling Y, Xu SB, Lin YX, et al. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients. Chin Med J (Engl). 2020; 133: 1039-1043.
[98]  Tang A, Tong ZD, Wang HL, et al. Detection of Novel Coronavirus by RT-PCR in Stool Specimen from Asymptomatic Child, China. Emerg Infect Dis. 2020; 26: 1337-1339.
[99]  Wang X, Zhou Z, Zhang J, et al. A case of 2019 Novel Coronavirus in a pregnant woman with preterm delivery. Clin Infect Dis. 2020.
[100]  Chen H, Guo J, Wang C, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020; 395: 809-815.
[101]  Kam KQ, Yung CF, Cui L, et al. A Well Infant with Coronavirus Disease 2019 (COVID-19) with High Viral Load. Clin Infect Dis. 2020.
[102]  Wang L, Shi Y, Xiao T, et al. Chinese expert consensus on the perinatal and neonatal management for the prevention and control of the 2019 novel coronavirus infection (First edition). Ann Transl Med. 2020; 8: 47.
[103]  Liang W, Feng Z, Rao S, et al. Diarrhoea may be underestimated: a missing link in 2019 novel coronavirus. Gut. 2020; 69: 1141-1143.
[104]  Gao QY, Chen YX, Fang JY. 2019 novel coronavirus infection and gastrointestinal tract. J Dig Dis. 2020; 21: 125-126.
[105]  Kruse RL. Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China. F1000Res. 2020; 9: 72.
[106]  Guan GW, Gao L, Wang JW, et al. [Exploring the mechanism of liver enzyme abnormalities in patients with novel coronavirus-infected pneumonia]. Zhonghua Gan Zang Bing Za Zhi. 2020; 28: E002.
[107]  Yao N, Wang SN, Lian JQ, et al. [Clinical characteristics and influencing factors of patients with novel coronavirus pneumonia combined with liver injury in Shaanxi region]. Zhonghua Gan Zang Bing Za Zhi. 2020; 28: E003.
[108]  Multicenter collaboration group of department of science and technology of Guangdong province and health commission of Guangdong province for chloroquine in the treatment of novel coronavirus pneumonia. [Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia]. Zhonghua Jie He He Hu Xi Za Zhi. 2020; 43: E019.
[109]  Martinez MA. Compounds with therapeutic potential against novel respiratory 2019 coronavirus. Antimicrob Agents Chemother. 2020; 64: e00399-20.
[110]  Shanmugaraj B, Malla A, Phoolcharoen W. Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development. Pathogens. 2020; 9: E148.
[111]  Prompetchara E, Ketloy C, Palaga T. Immune Responses in COVID-19 and Potential Vaccines: Lessons Learned From SARS and MERS Epidemic. Asian Pac J Allergy Immunol 2020; 38: 1-9.
[112]  Bhattacharya M, Ranjan Sharma A, Patra P, et al. of epitope-based peptide vaccine against novel Coronavirus 2019 (SARS-COV-2): Immunoinformatics approach. J Med Virol. 2020.
[113]  Ahmed SF, Quadeer AA, McKay MR. Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies. Viruses; 2020; 12: 254.
[114]  Moriyama M, Hugentobler WJ, Iwasaki A. Seasonality of Respiratory Viral Infections. Annu Rev Virol. 2020.
[115]  Watkins J. Preventing a covid-19 pandemic. BMJ. 2020; 368: m810.
[116]  Bénézit F, Loubet P, Galtier F, et al. Non-influenza respiratory viruses in adult patients admitted with influenza-like illness: a 3-year prospective multicenter study. Infection. 2020.
[117]  Nazareth R, Chasqueira MJ, Rodrigues ML, et al. Respiratory viruses in mechanically ventilated patients: a pilot study. BMC Pulm Med. 2020; 20: 39.
[118]  McCallum L, Partridge J. Epidemiological characteristics of the influenza A(H1N1) 2009 pandemic in the Western Pacific Region. Western Pac Surveill Response J. 2010; 1: 5-11.
[119]  Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. JAMA 2020.
[120]  MacIntyre CR. On a knife's edge of a COVID-19 pandemic: is containment still possible? Public Health Res Pract. 2020; 30: 3012000.
[121]  Nishiura H, Kobayashi T, Yang Y, et al. The Rate of Underascertainment of Novel Coronavirus (2019-nCoV) Infection: Estimation Using Japanese Passengers Data on Evacuation Flights. J Clin Med. 2020; 9: 419.
[122]  [No authors listed]. Coronavirus response: a focus on containment is still apt. Nature. 2020; 579: 7.
[123]  Riou J, Althaus CL. Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020. Euro Surveill. 2020; 25: 2000058.
[124]  Rello J, Tejada S, Userovici C, et al. Coronavirus Disease 2019 (COVID-19): A critical care perspective beyond China. Anaesth Crit Care Pain Med. 2020: 39: 167-169.
[125]  Rodriguez-Morales AJ, Bonilla-Aldana DK, Balbin-Ramon GJ, et al. History is repeating itself: Probable zoonotic spillover as the cause of the 2019 novel Coronavirus Epidemic. Infez Med. 2020; 28: 3-5.
[126]  Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395: 565-574.
[127]  Delogu M, Cotti C, Lelli D, et al. Eco-Virological Preliminary Study of Potentially Emerging Pathogens in Hedgehogs (Erinaceus europaeus) Recovered at a Wildlife Treatment and Rehabilitation Center in Northern Italy. Animals (Basel). 2020; 10: 407.
[128]  Bhadelia N. Coronavirus: hospitals must learn from past pandemics. Nature. 2020; 578: 193.
[129]  Ding Q, Lu P, Fan Y, et al. The clinical characteristics of pneumonia patients co-infected with 2019 novel coronavirus and influenza virus in Wuhan, China. J Med Virol. 2020.
[130]  Bordi L, Nicastri E, Scorzolini L, et al. Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020. Euro Surveill. 2020; 25: 2000170.
[131]  Wu X, Cai Y, Huang X, et al. Co-infection with SARS-CoV-2 and Influenza A Virus in Patient with Pneumonia, China. Emerg Infect Dis. 2020; 26: 1324-1326.
[132]  Ng Y, Li Z, Chua YX, et al. Evaluation of the Effectiveness of Surveillance and Containment Measures for the First 100 Patients with COVID-19 in Singapore - January 2-February 29, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69: 307-311.
[133]  Tolksdorf K, Buda S, Schuler E, et al. Influenza-associated pneumonia as reference to assess seriousness of coronavirus disease (COVID-19). Euro Surveill. 2020; 25: 2000258.
[134]  Li TG, Wang M. [Be alert to superposed effect of seasonal influenza while fighting against novel coronavirus pneumonia]. Zhonghua Yu Fang Yi Xue Za Zhi. 2020; 54: E002.
[135]  D'Antiga L. Coronaviruses and immunosuppressed patients. The facts during the third epidemic. Liver Transpl. 2020; 26: 832-834.
[136]  Anderson PO. Breastfeeding and Respiratory Antivirals: Coronavirus and Influenza. Breastfeed Med. 2020; 15: 128.
[137]  Livingston E, Bucher K, Rekito A. Coronavirus Disease 2019 and Influenza. JAMA. 2020: 323: 1122.
[138]  Holshue ML, DeBolt C, Lindquist S, et al. First Case of 2019 Novel Coronavirus in the United States. N Engl J Med. 2020; 382: 929-936.
[139]  Ghinai I, McPherson TD, Hunter JC, et al. First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA. Lancet. 2020: 395: 1137-1144.
[140]  Ye B, Fan C, Pan Y, et al. [Which sampling method for the upper respiratory tract specimen should be taken to diagnose patient with COVID-19?]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2020; 55: E003.
[141]  Zhang N, Wang L, Deng X, et al. Recent advances in the detection of respiratory virus infection in humans. J Med Virol. 2020; 92: 408-417.
[142]  Shirato K, Nao N, Katano H, et al. Development of Genetic Diagnostic Methods for Novel Coronavirus 2019 (nCoV-2019) in Japan. Jpn J Infect Dis. 2020.
[143]  An P, Song P, Lian K, Wang Y. CT Manifestations of Novel Coronavirus Pneumonia: A Case Report. Balkan Med J. 2020; 37: 163-165.
[144]  McCarty MF, DiNicolantonio JJ. Nutraceuticals have potential for boosting the type 1 interferon response to RNA viruses including influenza and coronavirus. Prog Cardiovasc Dis. 2020.
[145]  Di Pierro F, Bertuccioli A, Cavecchia I. Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus. Minerva Gastroenterol Dietol. 2020.
[146]  Gurwitz D. Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics. Drug Dev Res. 2020.
[147]  Zhang L, Liu Y. Potential interventions for novel coronavirus in China: A systematic review. J Med Virol. 2020; 92: 479-490.
[148]  Lin Q, Zhao S, Gao D, et al. A conceptual model for the coronavirus disease 2019 (COVID-19) outbreak in Wuhan, China with individual reaction and governmental action. Int J Infect Dis. 2020; 93: 211-216.
[149]  Kain T, Fowler R. Preparing intensive care for the next pandemic influenza. Crit Care. 2019; 23: 337.
[150]  Liew MF, Siow WT, Yau YW, See KC. Safe patient transport for COVID-19. Crit Care. 2020; 24: 94.
[151]  Koonin LM. Novel coronavirus disease (COVID-19) outbreak: Now is the time to refresh pandemic plans. J Bus Contin Emer Plan. 2020; 13: 1-15.
[152]  Kamel Boulos MN, Geraghty EM. Geographical tracking and mapping of coronavirus disease COVID-19/severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic and associated events around the world: how 21st century GIS technologies are supporting the global fight against outbreaks and epidemics. Int J Health Geogr. 2020; 19: 8.
[153]  Spiteri G, Fielding J, Diercke M, et al. First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020. Euro Surveill. 2020; 25: 2000178.
[154]  Al-Qaness MAA, Ewees AA, Fan H, Abd El Aziz M. Optimization Method for Forecasting Confirmed Cases of COVID-19 in China. J Clin Med. 2020; 9: 674.
[155]  van der Werf S, Peltékian C. Émergence du coronavirus SARS-CoV2: faire face à l'épidémie de COVID-19. Virologie (Montrouge). 2020: 24: e12-15.
[156]  Lai A, Bergna A, Acciarri C, Galli M, Zehender G. Early phylogenetic estimate of the effective reproduction number of SARS-CoV-2. J Med Virol. 2020.
[157]  Matsuyama S, Nao N, Shirato K, et al. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells. Proc Natl Acad Sci U S A. 2020: 117: 7001-7003.
[158]  Stoffel C, Schuppers M, Buholzer P, et al. The ongoing crises in China illustrate that the assessment of epidemics in isolation is no longer sufficient. Transbound Emerg Dis. 2020: 67: 1043-1044.